| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Resolving the resolution of array CGH.
|
Genomics
|
2007
|
3.66
|
|
2
|
BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH).
|
Nucleic Acids Res
|
2006
|
3.32
|
|
3
|
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
|
Gastroenterology
|
2008
|
3.18
|
|
4
|
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.
|
Cancer Res
|
2008
|
3.06
|
|
5
|
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect.
|
Nat Genet
|
2005
|
2.71
|
|
6
|
Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients.
|
J Clin Oncol
|
2006
|
2.33
|
|
7
|
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
|
J Natl Cancer Inst
|
2009
|
2.22
|
|
8
|
Human and mouse oligonucleotide-based array CGH.
|
Nucleic Acids Res
|
2005
|
2.03
|
|
9
|
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.
|
J Clin Oncol
|
2007
|
1.97
|
|
10
|
Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
|
Am J Gastroenterol
|
2010
|
1.90
|
|
11
|
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.
|
Cancer Res
|
2009
|
1.80
|
|
12
|
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
|
Clin Cancer Res
|
2009
|
1.78
|
|
13
|
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.
|
Mol Cancer
|
2010
|
1.69
|
|
14
|
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.
|
Cancer Res
|
2008
|
1.69
|
|
15
|
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
|
Gut
|
2010
|
1.68
|
|
16
|
Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.55
|
|
17
|
Colorectal cancer epigenetics: complex simplicity.
|
J Clin Oncol
|
2011
|
1.47
|
|
18
|
Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.
|
Cell Oncol
|
2004
|
1.46
|
|
19
|
Smoothing waves in array CGH tumor profiles.
|
Bioinformatics
|
2009
|
1.45
|
|
20
|
Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study.
|
Am J Gastroenterol
|
2009
|
1.44
|
|
21
|
Macrophages direct tumour histology and clinical outcome in a colon cancer model.
|
J Pathol
|
2005
|
1.40
|
|
22
|
Genomic profiling of gastric cancer predicts lymph node status and survival.
|
Oncogene
|
2003
|
1.40
|
|
23
|
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
|
Carcinogenesis
|
2007
|
1.32
|
|
24
|
Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice.
|
Gastrointest Endosc
|
2010
|
1.27
|
|
25
|
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.
|
Genes Chromosomes Cancer
|
2008
|
1.26
|
|
26
|
Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations.
|
Genes Chromosomes Cancer
|
2008
|
1.25
|
|
27
|
Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
|
Cancer Prev Res (Phila)
|
2011
|
1.23
|
|
28
|
Rapid quantification of myocardial fibrosis: a new macro-based automated analysis.
|
Cell Oncol (Dordr)
|
2011
|
1.22
|
|
29
|
Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
|
J Pathol
|
2003
|
1.21
|
|
30
|
Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha).
|
Oncogene
|
2003
|
1.20
|
|
31
|
Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study.
|
BMC Cancer
|
2010
|
1.20
|
|
32
|
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
|
J Mol Diagn
|
2012
|
1.19
|
|
33
|
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.
|
Tumour Biol
|
2010
|
1.16
|
|
34
|
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
|
Mol Cell Proteomics
|
2010
|
1.16
|
|
35
|
Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
|
Cancer Res
|
2005
|
1.16
|
|
36
|
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
|
Gut
|
2011
|
1.15
|
|
37
|
The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
|
Cancer Immunol Immunother
|
2006
|
1.14
|
|
38
|
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.
|
PLoS One
|
2008
|
1.14
|
|
39
|
Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis.
|
Genes Chromosomes Cancer
|
2012
|
1.10
|
|
40
|
Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
|
Cell Oncol (Dordr)
|
2014
|
1.09
|
|
41
|
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.
|
PLoS One
|
2009
|
1.06
|
|
42
|
Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions.
|
Helicobacter
|
2010
|
1.05
|
|
43
|
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers.
|
Virchows Arch
|
2009
|
1.04
|
|
44
|
Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
|
J Proteomics
|
2010
|
1.04
|
|
45
|
Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
|
J Pathol
|
2010
|
1.03
|
|
46
|
Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
|
Clin Biochem
|
2012
|
1.03
|
|
47
|
Promoter methylation precedes chromosomal alterations in colorectal cancer development.
|
Cell Oncol
|
2006
|
1.03
|
|
48
|
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
|
Carcinogenesis
|
2009
|
1.03
|
|
49
|
Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
|
Cell Oncol (Dordr)
|
2012
|
1.02
|
|
50
|
Interval cancers after colonoscopy-insights and recommendations.
|
Nat Rev Gastroenterol Hepatol
|
2012
|
1.02
|
|
51
|
Alternative cleavage and polyadenylation during colorectal cancer development.
|
Clin Cancer Res
|
2012
|
1.02
|
|
52
|
Molecular tests for colorectal cancer screening.
|
Clin Colorectal Cancer
|
2011
|
1.01
|
|
53
|
Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
|
Int J Cancer
|
2011
|
1.01
|
|
54
|
A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.
|
Fam Cancer
|
2004
|
1.00
|
|
55
|
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations.
|
Cancer Res
|
2005
|
1.00
|
|
56
|
Colonoscopic yield of colorectal neoplasia in daily clinical practice.
|
World J Gastroenterol
|
2009
|
1.00
|
|
57
|
DNA quality assessment for array CGH by isothermal whole genome amplification.
|
Cell Oncol
|
2007
|
0.99
|
|
58
|
CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material.
|
Genes Chromosomes Cancer
|
2011
|
0.99
|
|
59
|
18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.
|
J Cancer Res Clin Oncol
|
2007
|
0.97
|
|
60
|
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
|
Gut
|
2011
|
0.96
|
|
61
|
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
|
Cancer Res
|
2009
|
0.96
|
|
62
|
DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma.
|
Clin Cancer Res
|
2007
|
0.95
|
|
63
|
High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas.
|
Clin Cancer Res
|
2010
|
0.95
|
|
64
|
Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications.
|
J Pathol
|
2003
|
0.93
|
|
65
|
Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy.
|
Prostate
|
2007
|
0.93
|
|
66
|
MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data.
|
Cell Oncol
|
2008
|
0.92
|
|
67
|
Cell cycle proteins predict recurrence in stage II and III colon cancer.
|
Ann Surg Oncol
|
2012
|
0.92
|
|
68
|
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
|
BMC Cancer
|
2012
|
0.92
|
|
69
|
Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.
|
BMC Cancer
|
2011
|
0.92
|
|
70
|
DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.
|
Am J Respir Crit Care Med
|
2011
|
0.92
|
|
71
|
Detection limits of DNA copy number alterations in heterogeneous cell populations.
|
Cell Oncol (Dordr)
|
2012
|
0.92
|
|
72
|
Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand.
|
BMC Cancer
|
2012
|
0.92
|
|
73
|
Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes.
|
Int J Cancer
|
2009
|
0.92
|
|
74
|
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study.
|
BMC Gastroenterol
|
2012
|
0.91
|
|
75
|
DNA copy number profiles of gastric cancer precursor lesions.
|
BMC Genomics
|
2007
|
0.91
|
|
76
|
Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer.
|
Oncologist
|
2012
|
0.91
|
|
77
|
Rapid quantification of myocardial fibrosis: A new macro-based automated analysis.
|
Anal Cell Pathol (Amst)
|
2010
|
0.90
|
|
78
|
Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum.
|
Virchows Arch
|
2008
|
0.90
|
|
79
|
Stepwise classification of cancer samples using clinical and molecular data.
|
BMC Bioinformatics
|
2011
|
0.90
|
|
80
|
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.
|
BMC Med Genomics
|
2009
|
0.89
|
|
81
|
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.
|
Genome Biol
|
2014
|
0.89
|
|
82
|
The adenoma hunt in colorectal cancer screening: defining the target.
|
J Pathol
|
2011
|
0.88
|
|
83
|
Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes.
|
Blood
|
2005
|
0.88
|
|
84
|
Gastric cancers of Western European and African patients show different patterns of genomic instability.
|
BMC Med Genomics
|
2011
|
0.88
|
|
85
|
Loss of 1p36, gain of 8q24, and loss of 9q34 are associated with stroma percentage of colorectal cancer.
|
Cancer Lett
|
2007
|
0.88
|
|
86
|
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
|
Ann Surg
|
2016
|
0.87
|
|
87
|
Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA).
|
Risk Anal
|
2013
|
0.87
|
|
88
|
Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.
|
Cancer Sci
|
2012
|
0.87
|
|
89
|
Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components.
|
Cell Oncol
|
2006
|
0.87
|
|
90
|
Promoter CpG island methylation markers in colorectal cancer: the road ahead.
|
Epigenomics
|
2012
|
0.87
|
|
91
|
Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma.
|
Mod Pathol
|
2004
|
0.86
|
|
92
|
BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
|
J Pathol
|
2011
|
0.86
|
|
93
|
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
|
Cell Oncol (Dordr)
|
2012
|
0.86
|
|
94
|
Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.
|
Genes Chromosomes Cancer
|
2009
|
0.86
|
|
95
|
Similar fecal immunochemical test results in screening and referral colorectal cancer.
|
World J Gastroenterol
|
2012
|
0.86
|
|
96
|
EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.
|
Lung Cancer
|
2013
|
0.85
|
|
97
|
Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.
|
Clin Cancer Res
|
2011
|
0.85
|
|
98
|
Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis.
|
Am J Gastroenterol
|
2013
|
0.85
|
|
99
|
The SPINK gene family and celiac disease susceptibility.
|
Immunogenetics
|
2007
|
0.84
|
|
100
|
Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability.
|
Genes Chromosomes Cancer
|
2008
|
0.84
|
|
101
|
Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results.
|
Gastrointest Endosc
|
2012
|
0.84
|
|
102
|
CGHpower: exploring sample size calculations for chromosomal copy number experiments.
|
BMC Bioinformatics
|
2010
|
0.84
|
|
103
|
Functional microRNA screening using a comprehensive lentiviral human microRNA expression library.
|
BMC Genomics
|
2011
|
0.84
|
|
104
|
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
|
Cancer Prev Res (Phila)
|
2011
|
0.83
|
|
105
|
Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
|
Cell Oncol (Dordr)
|
2012
|
0.83
|
|
106
|
To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!
|
Clin Cancer Res
|
2011
|
0.83
|
|
107
|
Salivary gland carcinosarcoma: oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components.
|
Oral Oncol
|
2008
|
0.83
|
|
108
|
Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases.
|
J Thorac Oncol
|
2007
|
0.83
|
|
109
|
Chromosomes and cancer, Boveri revisited.
|
Cell Oncol
|
2005
|
0.82
|
|
110
|
The 13th Fanconi anemia gene identified: FANCI--importance of the 'Fanconi anemia pathway' for cellular oncology.
|
Cell Oncol
|
2007
|
0.82
|
|
111
|
Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces.
|
Ann Surg
|
2008
|
0.82
|
|
112
|
Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
|
Genes Chromosomes Cancer
|
2014
|
0.82
|
|
113
|
Comparative evaluation of genetic assays to identify oral pre-cancerous fields.
|
J Oral Pathol Med
|
2008
|
0.82
|
|
114
|
Carcinoma origin dictates differential skewing of monocyte function.
|
Oncoimmunology
|
2012
|
0.82
|
|
115
|
Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
|
BMC Cancer
|
2013
|
0.81
|
|
116
|
Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways.
|
Cell Oncol
|
2009
|
0.81
|
|
117
|
High resolution microarray CGH and MLPA analysis for improved genotype/phenotype evaluation of two childhood genetic disorder cases: ring chromosome 19 and partial duplication 2q.
|
Eur J Med Genet
|
2005
|
0.81
|
|
118
|
Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma.
|
Mod Pathol
|
2006
|
0.81
|
|
119
|
Comparative genomic hybridization in cancer investigations.
|
Methods Mol Biol
|
2002
|
0.81
|
|
120
|
DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer.
|
Thorax
|
2013
|
0.80
|
|
121
|
Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.
|
Eur J Hum Genet
|
2010
|
0.80
|
|
122
|
Comprehensive mutation analysis in colorectal flat adenomas.
|
PLoS One
|
2012
|
0.80
|
|
123
|
Lumican and versican are associated with good outcome in stage II and III colon cancer.
|
Ann Surg Oncol
|
2012
|
0.79
|
|
124
|
Computer-assisted estimation in the CNS of 3D multimarker 'overlap' or 'touch' at the level of individual nerve endings: a confocal laser scanning microscope application.
|
J Neurosci Res
|
2007
|
0.79
|
|
125
|
Chromosome 5q loss in colorectal flat adenomas.
|
Clin Cancer Res
|
2012
|
0.79
|
|
126
|
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
|
Cell Oncol (Dordr)
|
2013
|
0.79
|
|
127
|
Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
|
Clin Cancer Res
|
2012
|
0.79
|
|
128
|
Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.
|
Mediators Inflamm
|
2013
|
0.79
|
|
129
|
Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
|
Genes Chromosomes Cancer
|
2009
|
0.78
|
|
130
|
Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer.
|
Gut
|
2012
|
0.78
|
|
131
|
The future of colorectal cancer: implications of screening.
|
Gut
|
2013
|
0.77
|
|
132
|
Implementation of accurate and fast DNA cytometry by confocal microscopy in 3D.
|
Cell Oncol
|
2005
|
0.76
|
|
133
|
NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.
|
BMC Med Genomics
|
2009
|
0.76
|
|
134
|
Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.
|
J Surg Oncol
|
2013
|
0.76
|
|
135
|
Genomic aberrations relate early and advanced stage ovarian cancer.
|
Cell Oncol (Dordr)
|
2012
|
0.75
|
|
136
|
Comment re: a comparison of DNA copy number profiling platforms.
|
Cancer Res
|
2008
|
0.75
|
|
137
|
Chromosome 20 aberrations at the diploid-aneuploid transition in sporadic colorectal cancer.
|
Cytogenet Genome Res
|
2014
|
0.75
|
|
138
|
A protein shot for biomedical research.
|
J Intern Med
|
2011
|
0.75
|
|
139
|
Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study.
|
Eur J Gastroenterol Hepatol
|
2012
|
0.75
|
|
140
|
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients.
|
Immunobiology
|
2006
|
0.75
|
|
141
|
[Diagnosis of colorectal tumours in daily clinical practice: comparison of colonoscopy and sigmoidoscopy].
|
Ned Tijdschr Geneeskd
|
2009
|
0.75
|
|
142
|
Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication.
|
Digestion
|
2004
|
0.75
|
|
143
|
[Consent for the secondary use of human residual tissue: the patient is best served by an 'opting-out' procedure].
|
Ned Tijdschr Geneeskd
|
2012
|
0.75
|
|
144
|
[Colorectal carcinoma in the Netherlands: the situation before and after population surveillance].
|
Ned Tijdschr Geneeskd
|
2014
|
0.75
|